Company intelligence / Profile preview

Zoyi Capital

Ownership: Private
Development stage: Other

Overview

Zoyi Capital is not a life science/biotech/pharma/healthcare company but rather a private equity investment firm founded in Taiwan in 2013. Its focus has been on investing in established mid-market businesses within the Greater China region. There is no evidence that it operates directly within health-related sectors or develops therapeutic products. No clinical pipeline exists for this entity.

Industry: Investors

Partnerships

none known specific to pharma/biotech/life sciences

Beyond the preview

Go deeper on Zoyi Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zoyi Capital.

Explore the full profile